Core Insights - The overall performance of the New Third Board companies showed resilience, with a revenue of 1.49 trillion yuan and a net profit of 52.77 billion yuan in 2022, despite a year-on-year decline in net profit by 8.37% for non-financial enterprises [1] - The New Third Board companies demonstrated strong operational capabilities, with nearly 70% of companies achieving profitability [1] Group 1: Financial Performance - In 2022, 346 companies on the New Third Board reported a net profit exceeding 50 million yuan, contributing to a total net profit of 42.17 billion yuan, which accounts for about 50% of the profits from profitable companies [2] - The average return on equity for these companies was 15.09%, with a net profit growth rate of 41.16% [2] - The total interest-bearing liabilities of the listed companies reached 362.02 billion yuan by the end of 2022, reflecting a 13.77% increase from the beginning of the year [2] Group 2: Policy Support and Taxation - The companies benefited from government policies such as loan repayment extensions, which improved their financial structure and alleviated turnover pressure [2] - The total tax paid by the listed companies was 50.99 billion yuan, representing 3.42% of their revenue, a decrease from previous years [2] Group 3: Innovation and Growth - The New Third Board has seen a significant increase in specialized and innovative "little giant" enterprises, with 689 such companies now listed, accounting for over 40% of the market [3] - New listings in 2022 included 270 companies, with a median net profit of 22.94 million yuan, significantly higher than the overall median [3] - The average return on equity for new listings was 15.62%, exceeding the market average by over 10 percentage points [3] Group 4: North Exchange Preparations - As of April 28, 443 companies were preparing for listing on the North Exchange, marking a 10.20% increase from the previous year [4] - These companies had an average compound annual growth rate of net profit of 17.20% over the past two years, with R&D expenses averaging 17.30 million yuan, about twice the market average [4]

Core Viewpoint - The article discusses the rising trend of mergers and acquisitions (M&A) in the investment sector, emphasizing the concept of "differentiated pricing" in transactions, particularly in the context of the acquisition of Pengli Bio by Aopumai [2][3][9]. Group 1: M&A Trends - The investment community is increasingly referring to a "golden age of M&A," driven by a return to reasonable asset valuations and supportive government policies [2][3]. - Aopumai's acquisition of Pengli Bio exemplifies this trend, with the final transaction price set at approximately 1.451 billion yuan, reflecting a significant discount compared to previous valuations [2][9]. Group 2: Differentiated Pricing - The concept of "differentiated pricing" is becoming more common in M&A transactions, allowing for tailored exit strategies for various investors involved in the target company [3][5]. - Aopumai's acquisition involved setting four different pricing tiers for the investors in Pengli Bio, ranging from 1.24 billion yuan to 2.18 billion yuan, showcasing the flexibility in structuring deals [4][12]. Group 3: Case Studies - The article references other similar cases, such as Zhaoyi Innovation's acquisition of Saixin Electronics, which also employed differentiated pricing strategies [5][14]. - The acquisition of Pengli Bio is highlighted as a typical case, with its history of rapid valuation increases followed by a significant discount during the acquisition process [9][10]. Group 4: Market Implications - The article suggests that M&A activities are a means to alleviate market bubbles and provide liquidity to investors who have been trapped in illiquid positions due to a cooling IPO market [11][12]. - The involvement of various institutional investors in Pengli Bio's funding rounds indicates a complex ownership structure, which adds layers of negotiation in M&A transactions [13][10]. Group 5: Future Outlook - The trend of differentiated pricing is expected to continue growing in the M&A landscape, as it provides a practical tool for achieving consensus among diverse stakeholders [6][18]. - The article concludes that the M&A market is likely to remain active, driven by the need for capital flow and the resolution of complex ownership structures in target companies [19][20].

将投中网设为"星标⭐"，第一时间收获最新推送 并购流行起"差异化对价"。 作者丨蒲凡 编辑丨张楠 来源丨 投中网 最近一年，投资圈越来越流行"并购进入黄金时代"的说法。人们给出的理由主要有两个，一个是目前距离美元大放水时代已经整整过去了4年，创业者们 不再抱有幻想、投资人们没有了耐心，优质资产纷纷回到一个合理的估值区间，是抄底的好窗口；另一个是新"国九条""科创板八条"等一系列政策出 台，赋予了"并购"前所未有的正面定性，买方数量将大大增加。 近日，上海奥浦迈生物科技股份有限公司（以下简称"奥浦迈"）宣布将收购澎立生物医药技术（上海）股份有限公司（以下简称"澎立生物"）。交易对 手除了澎立生物实控人JIFENG DUAN控制的实体外，均是澎立生物的外部投资机构。经奥浦迈与交易对方充分协商，澎立生物100%股权的最终交易总 价约为14.51亿元。 这笔交易再一次复现了2023年底，歌尔股份收购驭光科技的操作，即相比最后一轮融资，收购折价近半。根据奥浦迈发布的公告， 澎立生物用2年半时 间完成了估值1460%的倍增，又在3年后出现了55%的折价，过程中"欲IPO而不得"，最终被一家营收规模、净利润都未明显强于自己 ...

Key Insights - The report highlights the resilience of the Chinese market amidst global uncertainties, emphasizing the advantages of domestic circulation and the potential for growth in the equity market [6][9][12] - The report discusses the impact of U.S. tariffs on Chinese exports, estimating a negative effect of approximately 8-10 percentage points on export growth and a 1.5-2.0 percentage point impact on GDP [5][21] - The report outlines the government's commitment to boosting domestic consumption through various policies, including a significant increase in special bonds for consumer subsidies [25][28] Macro Analysis - The U.S. CPI rose by 2.4% year-on-year in March, while China's CPI is expected to face downward pressure, with a forecasted decline of around -0.4% in April [1][21] - The report anticipates that the Chinese government will implement a fiscal stimulus of 1.5-2 trillion yuan to support domestic demand and consumption [21][22] - The report notes that the core CPI has shown signs of recovery, with a year-on-year increase of 0.5% in March, indicating potential stabilization in consumer prices [19][22] Banking Sector - The report emphasizes the role of central financial institutions, such as the Central Huijin Investment, in stabilizing market expectations by increasing their holdings in ETFs [9][10] - It highlights the expected continuation of a low-interest-rate environment, which enhances the attractiveness of bank dividends and low volatility [13][12] - The report suggests that the banking sector is poised for a valuation reset, driven by increased long-term capital inflows and improved market efficiency [12][13] Consumer Sector - The report discusses the expansion of the "immediate refund" tax policy for foreign tourists, which is expected to stimulate domestic consumption and benefit high-quality domestic products [25][26][28] - It notes that the government's focus on boosting consumption is reflected in various initiatives aimed at enhancing consumer spending capabilities [25][28] - The report anticipates that the combination of the "immediate refund" policy and relaxed entry visa regulations will significantly contribute to the growth of inbound tourism consumption [26][28] Company-Specific Insights - Gu Ming (古茗) is identified as a leading brand in the Chinese tea beverage market, with a strong focus on quality and a robust expansion strategy [34][36] - The company has maintained a high average profit margin for franchisees, indicating strong brand recognition and operational efficiency [35][36] - The report highlights the company's commitment to supply chain management and R&D investment, positioning it well for future growth in the competitive market [35][36] Industry Trends - Tai Chi Co., Ltd. (太极股份) is noted for its strategic focus on AI and domestic innovation, with expectations for performance improvement in the latter half of the year [38][39] - The company has reported a decline in revenue and profit but is expected to benefit from the acceleration of domestic innovation initiatives [38][41] - The report emphasizes the importance of integrating advanced technologies to enhance service capabilities and drive future growth [40][41]